The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa

Conclusions
The GPR is a more accurate routine laboratory marker than APRI and Fib-4 to stage liver fibrosis in patients with CHB in West Africa. The GPR represents a simple and inexpensive alternative to liver biopsy and Fibroscan in sub-Saharan Africa.

Source: Gut - July 7, 2016 Category: Gastroenterology Authors: Lemoine, M., Shimakawa, Y., Nayagam, S., Khalil, M., Suso, P., Lloyd, J., Goldin, R., Njai, H.-F., Ndow, G., Taal, M., Cooke, G., D'Alessandro, U., Vray, M., Mbaye, P. S., Njie, R., Mallet, V., Thursz, M. Tags: Cirrhosis, Open access Hepatology Source Type: research